| Literature DB >> 35284682 |
Jane N C Okafor1,2, Victoria A Jideani1, Mervin Meyer3, Marilize Le Roes-Hill4.
Abstract
The utilization of nutraceuticals on a global scale has significantly increased over the past few years due to their reported health benefits and consumer's reluctance to consume synthetic drugs. This paper provides information regarding new and potential value added uses of biologically active compounds in Bambara groundnut (BGN) as ingredients that could be further researched and exploited for various applications. Nutraceutical is a food or part of food that apart from providing basic nutrients, offers medicinal benefits either by prevention and or treatment of an illness. BGN is a legume with rich nutrient profile that is under exploited industrially. It is widely used in African traditional medicine for its various health outcome, but has not been explored scientifically for its numerous nutraceutical potentials. Compared to beans BGN has greater quantity of soluble fiber and also have high dietary fiber. It is rich in polyphenolic compound which include flavonoids subgroups like flavonols, flavanols, anthocyanindins, isoflavones and phenolic acids: both benzoic acid and cinnamic acid derivatives, biologically active polyunsaturated fatty acids, proteins and peptides, antioxidant vitamins and minerals. The rising interest and emphasis in plant-based biologically active components (nutraceuticals) for various health promotion, has positioned this African legume as a potential source of nutraceutical ingredients (bioactive components) that could be exploited for improved nutrition and health.Entities:
Keywords: (Vigna subterraenea (L.) Verdc); Bioactive components; Biological activity; Medicinal benefit; Phytochemicals
Year: 2022 PMID: 35284682 PMCID: PMC8913303 DOI: 10.1016/j.heliyon.2022.e09024
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
The traditional medicine utilization of BGN for various health enhancement in different African countries.
| Local name | Type of BGN | Traditional Medicinal use | Country | Reference |
|---|---|---|---|---|
| Njugo’ beans | Immature seeds and mature seeds | 1).To check nausea and vomiting and morning sickness during pregnancy. 2). Treatment of some malignancies and inflammatory disorders | South Africa | |
| Aboboi akyii | Black seeds | To alleviate swollen jaw diseases | Ghana | |
| Aboboi akyii | Milled seeds | To treat skin rashes and sick children | Ghana | |
| Aboboi akyii | Cream colored BGN seeds mixed with guinea fowl meat | treating diarrhea | Ghana | |
| Seeds of the mature black landrace | Treatment for impotence and in traditional medicine. | Botswana | ||
| Njugu mawe’ | Water boiled BGN and maize and | Use for treatment of diarrhoea. | Kenya | |
| Njugu mawe | Pound BGN leaves and | To wash livestock as a | ||
| Njugu mawe | BGN leaves pound with mexican marigold and | Serve as insecticide | ||
| Njugu mawe | leaves are pounded with traditional salt (‘mbala’), | Use in treatment of cattles infected with ‘tuoolao’ (a type of mouth disease) | ||
| Njugu mawe | Roasted BGN seeds | Use for treatment of polymenorrhea. | Luo tribe in Kenya | |
| Njugu mawe | roasted seeds | Use for treatment of polymenorrhea. | Luo tribe in Kenya | |
| Njugu mawe | Crushed seeds mixed with water | Use for treatment of cataracts. | Luo tribe in Kenya | |
| Njugu mawe | BGN seed flour diluted in water or water from cooked BGN seeds | Remedy for internal bruising; speed up the resorption of people suffering hematomas | Luo tribe in Kenya | |
| Okpa otuanya in Igbo (Nigeria), Epi roro in Yoruba and Guijiya | Cruised seeds mixed with water and cooked seeds | To treat venereal diseases and protein malnutrition related disorder | Nigeria | |
| Juga bean | Mature seeds | Recommended for treatment of polymenorrhea. | Zambia | |
| Njugu mawe | Seed flour diluted in water/cooking water | Remedy for internal bruising; speed up the resorption of people suffering hematomas | Luo tribe in Kenya | |
| Njugu mawe | Boiled or cruised or cooked seeds | Treatment of anaemia in children and peri-partum women within 1 month of delivery | Cô te d’Ivoire, | |
| Njugu mawe | Juice obtained from boiling BGN seeds and maize | Treatment of diarrhea | Cô te d’Ivoire, | |
| Njogo bean | BGN flour and flour from fruit of Puvpalia lappacea (L.) (Amaranthaceae) | Use as hemostatic drink, to treat menorrhagia during pregnancy, | Cô te d’Ivoire, | |
| Njogo bean | A decoction of seeds with leaves of | used as a drink to treat gonorrhea | Cô te d’Ivoire | |
| Njogo bean | Black BGN seeds mixed with unidentified plant | used for treatment of ulcers | Cô te d’Ivoire | |
| Njogo bean | Cooked Protein rich cream colored seeds | Helps to overcome Kwashiorkor, the common protein deficiency disease in young children | Central Africa |
Chemical composition and biologically active components in Bambara groundnut.
| Class/type of Nutraceutical | Raw | Cooked | Reference |
|---|---|---|---|
| Quercetin | 0.007–6.39 | 3.94 | |
| Quercitrin | 2.05 | 1.58 | |
| Isoquercitrin | 0.42 | 0.29 | |
| Kaempferol | 0.052–2.18 | 3.15 | |
| Rutin | 0.427–24.46 | 3.16 | |
| Myricetin | 0.062–1.800 | - | |
| Luteolin 1.09 | 1.09 | 1.67 | |
| Catechin | 0.01–2.34 | ||
| Epicatechin | 1.15 | 0.39 | |
| Caffeic acid | 3.65 | 3.75 | |
| Ellagic acid | 0.005–1.09 | 1.42 | |
| Cholorogenic acid | 0.03–2.37 | 0.50 | |
| Gallic acid | 0.05–1.03 | 0.41 | |
| Total dietary fibre, TDF (% of seed) | 1.61–10.30 | - | |
| Soluble dietary fiber (% of TDF) | 3.00–7.00 | - | |
| Insoluble dietary fibre, IDF (% of TDF) | 9.60–10.00 | - | |
| Ursonic acid (% of IDF) | 10.6–11.5 | - | |
| Arginine | 1.20–8.25 | - | |
| Isoleucine | 0.89 | - | |
| Leucine | 1.33–10.22 | - | |
| Lysine | 0.99–8.54 | - | |
| Glutamic acid | 3.21–21.38 | - | |
| monounsaturated fatty acids (MUFA) | 1073 | - | |
| polyunsaturated fatty acids (PUFA) | 2100 | - | |
| Saturated fatty acids | 1690 | - | |
| α-Tocopherol | 0.26 | - | |
| β-Tocopherol | - | - | |
| γ-Tocopherol | 1.05 | - | |
| δ-Tocopherol | 6.64 | - | |
| α-Tocotrienol | 0.10 | - | |
| β-Tocotrienol | - | - | |
| γ-Tocotrienol | 0.18 | - | |
| δ-Tocotrienol | - | - | |
| Campesterol | 0.73–3.93 | - | |
| Stigmasterol | 0.68–1.78 | - | |
| β–Sitosterol | 1.89–2.23 | - | |
In vitro and in vivo experiments showing the preventive, treatment and management potentials of BGN bioactive compounds against chronic diseases' molecular targets.
| Phytochemical | Biological effects | Experimental model | Molecular targets | Reference |
|---|---|---|---|---|
| BGN seed extracts rich in polyphenols and flavonoids | Antimutagenic and anticarcinogenic activity | mouse skin | Inhibition of tetradecanoyl-phorbol-3 acetate (TPA) induced expression of the | |
| BGN seed extract rich in polyphenols and flavonoids | Chemopreventive or chemoprotective activity | human breast epithelial (MCF10A) cells and in mouse skin | Inhibition of TPA-induced COX-2 expression by suppression of DNA binding of NF- | |
| Phytochemical rich extracts of BGN seeds | Inhibition of cancer cell proliferation | Hep-2 cancer cell line (human hepatic carcinoma), DU 145 (prostate cancer cell line) and noncancerous Vero cell line | Cytotoxic to cancer cells | |
| Phytochemical rich extracts | Modulation of activities of some enzymes relevant to erectile dysfunction | penile tissues of male wistar albino rats | Inhibition of arginase, phosphodiesterase-5 (PDE-5), acetylcholinesterase (AChE), and stimulation of ecto-5ʹ nucleotidase activities relevant to erectile dysfunction | |
| BGN seed Phenolics and peptides rich extracts | Demonstrated hypoglycemic and anticholinesterase activity | diabetic albino rats | Modulatory effect on α-amylase, α-glucosidase and acetylcholinesterase activities. | |
| BGN seed Phenolics rich extract | Antioxidant activity and DNA protection against oxidative damage. | pBR 322 plasmid DNA | protection of plasmid DNA against AAPH-induced oxidative damage | |
| BGN seed protein hydrolysates and peptides | Antihypertensive and antioxidant activity | Angiotensin converting enzyme (ACE) and Renin inhibition assay | Inhibition of angiotensin converting enzyme (ACE), renin enzyme, peroxidation of linoleic acid and free radical scavenging activities. | |
| BGN seed protein hydrolysates and peptides | Protection from cardiovascular diseases (CVD) and type-2 diabetes (T2D) and Oxidative stress | In vitro ACE activity, DPP-IV inhibitory activity and antioxidant assays. Simulated gastro intestinal digestion | Inhibition of angiotensin-converting enzyme (ACE), dipeptidyl peptidase-IV (DPP-IV), resistance to simulated gastrointestinal digestion (SGID) and antioxidant activity. | |
| Fermented BGN seed extract | Protection from hepatic tissue damage and oxidative stress | Diabetic Wister rats | Modulation of hepatic enzymes and oxidative stress | |
| Phenolic-rich extracts of fermented/unfermented BGN seeds | protection against oxidants and lipid peroxidation | Cow's liver homogenate in vitro | Inhibition of lipid peroxidation by prevention of TBARS production |